news2024-09-15T16:44:03+00:00#ESMO24: Scorpion details early data that helped it raise $150M for PI3Kɑ inhibitor
news2024-09-15T13:38:47+00:00New Data Presented at ESMO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer
news2024-09-14T14:30:42+00:00#ESMO24: Incyte gears up to face FDA once again with more Zynyz data in rare anal cancer
